225 related articles for article (PubMed ID: 29282288)
1. Structure-based virtual screening identifies a small-molecule inhibitor of the profilin 1-actin interaction.
Gau D; Lewis T; McDermott L; Wipf P; Koes D; Roy P
J Biol Chem; 2018 Feb; 293(7):2606-2616. PubMed ID: 29282288
[TBL] [Abstract][Full Text] [Related]
2. Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells.
Allen A; Gau D; Francoeur P; Sturm J; Wang Y; Martin R; Maranchie J; Duensing A; Kaczorowski A; Duensing S; Wu L; Lotze MT; Koes D; Storkus WJ; Roy P
J Biol Chem; 2020 Nov; 295(46):15636-15649. PubMed ID: 32883810
[TBL] [Abstract][Full Text] [Related]
3. Threonine 89 Is an Important Residue of Profilin-1 That Is Phosphorylatable by Protein Kinase A.
Gau D; Veon W; Zeng X; Yates N; Shroff SG; Koes DR; Roy P
PLoS One; 2016; 11(5):e0156313. PubMed ID: 27228149
[TBL] [Abstract][Full Text] [Related]
4. Disruption of profilin1 function suppresses developmental and pathological retinal neovascularization.
Gau D; Vignaud L; Allen A; Guo Z; Sahel J; Boone D; Koes D; Guillonneau X; Roy P
J Biol Chem; 2020 Jul; 295(28):9618-9629. PubMed ID: 32444495
[TBL] [Abstract][Full Text] [Related]
5. Profilin Directly Promotes Microtubule Growth through Residues Mutated in Amyotrophic Lateral Sclerosis.
Henty-Ridilla JL; Juanes MA; Goode BL
Curr Biol; 2017 Nov; 27(22):3535-3543.e4. PubMed ID: 29129529
[TBL] [Abstract][Full Text] [Related]
6. Profilin-1 negatively controls osteoclast migration by suppressing the protrusive structures based on branched actin filaments.
Kajikawa S; Ezura Y; Izu Y; Nakashima K; Noda M; Nifuji A
J Bone Miner Metab; 2022 Jul; 40(4):561-570. PubMed ID: 35428898
[TBL] [Abstract][Full Text] [Related]
7. ALS-linked PFN1 variants exhibit loss and gain of functions in the context of formin-induced actin polymerization.
Schmidt EJ; Funes S; McKeon JE; Morgan BR; Boopathy S; O'Connor LC; Bilsel O; Massi F; Jégou A; Bosco DA
Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34074767
[TBL] [Abstract][Full Text] [Related]
8. PFN2 and NAA80 cooperate to efficiently acetylate the N-terminus of actin.
Ree R; Kind L; Kaziales A; Varland S; Dai M; Richter K; Drazic A; Arnesen T
J Biol Chem; 2020 Dec; 295(49):16713-16731. PubMed ID: 32978259
[TBL] [Abstract][Full Text] [Related]
9. Visualizing molecules of functional
Pimm ML; Liu X; Tuli F; Heritz J; Lojko A; Henty-Ridilla JL
Elife; 2022 Jun; 11():. PubMed ID: 35666129
[TBL] [Abstract][Full Text] [Related]
10. Profilin 1 with the amyotrophic lateral sclerosis associated mutation T109M displays unaltered actin binding and does not affect the actin cytoskeleton.
Freischmidt A; Schöpflin M; Feiler MS; Fleck AK; Ludolph AC; Weishaupt JH
BMC Neurosci; 2015 Nov; 16():77. PubMed ID: 26572741
[TBL] [Abstract][Full Text] [Related]
11. Molecular insights on context-specific role of profilin-1 in cell migration.
Ding Z; Bae YH; Roy P
Cell Adh Migr; 2012; 6(5):442-9. PubMed ID: 23076048
[TBL] [Abstract][Full Text] [Related]
12. Genomes of Asgard archaea encode profilins that regulate actin.
Akıl C; Robinson RC
Nature; 2018 Oct; 562(7727):439-443. PubMed ID: 30283132
[TBL] [Abstract][Full Text] [Related]
13. Prolonged depletion of profilin 1 or F-actin causes an adaptive response in microtubules.
Cisterna BA; Skruber K; Jane ML; Camesi CI; Nguyen ID; Liu TM; Warp PV; Black JB; Butler MT; Bear JE; Mor DE; Read TA; Vitriol EA
J Cell Biol; 2024 Jul; 223(7):. PubMed ID: 38722279
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological intervention of MKL/SRF signaling by CCG-1423 impedes endothelial cell migration and angiogenesis.
Gau D; Veon W; Capasso TL; Bottcher R; Shroff S; Roman BL; Roy P
Angiogenesis; 2017 Nov; 20(4):663-672. PubMed ID: 28638990
[TBL] [Abstract][Full Text] [Related]
15. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness.
Zou L; Jaramillo M; Whaley D; Wells A; Panchapakesa V; Das T; Roy P
Br J Cancer; 2007 Nov; 97(10):1361-71. PubMed ID: 17940506
[TBL] [Abstract][Full Text] [Related]
16. Human profilin 1 is a negative regulator of CTL mediated cell-killing and migration.
Schoppmeyer R; Zhao R; Cheng H; Hamed M; Liu C; Zhou X; Schwarz EC; Zhou Y; Knörck A; Schwär G; Ji S; Liu L; Long J; Helms V; Hoth M; Yu X; Qu B
Eur J Immunol; 2017 Sep; 47(9):1562-1572. PubMed ID: 28688208
[TBL] [Abstract][Full Text] [Related]
17. Both actin and polyproline interactions of profilin-1 are required for migration, invasion and capillary morphogenesis of vascular endothelial cells.
Ding Z; Gau D; Deasy B; Wells A; Roy P
Exp Cell Res; 2009 Oct; 315(17):2963-73. PubMed ID: 19607826
[TBL] [Abstract][Full Text] [Related]
18. Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models.
Frantzi M; Klimou Z; Makridakis M; Zoidakis J; Latosinska A; Borràs DM; Janssen B; Giannopoulou I; Lygirou V; Lazaris AC; Anagnou NP; Mischak H; Roubelakis MG; Vlahou A
Oncotarget; 2016 Oct; 7(43):70750-70768. PubMed ID: 27683119
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of thymosin-β4/profilin exchange leading to actin filament polymerization.
Xue B; Leyrat C; Grimes JM; Robinson RC
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):E4596-605. PubMed ID: 25313062
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor activity of profilin requires a functional actin binding site.
Wittenmayer N; Jandrig B; Rothkegel M; Schlüter K; Arnold W; Haensch W; Scherneck S; Jockusch BM
Mol Biol Cell; 2004 Apr; 15(4):1600-8. PubMed ID: 14767055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
